Leading Justice is a full-service marketing company working with law firms on a cash buy basis to sign up fully-qualified, fraud-free cases associated with Nexium and Prilosec side effects. Here at Leading Justice, we can customize your firm’s Nexium and Prilosec advertising needs and help you sign up cases via internal cash buys. Our clients only pay an agency fee to cover the cost of Nexium and Prilosec advertising, plus a fee for each case we sign, and any data we generate for your firm belongs to you. In addition, we cross-qualify all of our contacts, meaning any data we generate that isn’t eligible for the target campaign is reviewed to find out if it qualifies for another type of claim. By using advanced approaches to target contacts specifically related to the popular heartburn drugs Nexium and Prilosec, and side effects like kidney damage, Leading Justice will increase your firm’s caseload. If you are interested in helping victims of alleged Nexium or Prilosec side effects, our extensive consumer reach and direct advertising strategies give you the competitive edge and confidence to allocate your full budget, and rest easy knowing your money is being spent in the best way possible.
Each and every law firm we work with at Leading Justice plays a role in determining how we classify Nexium and Prilosec claims as qualified or not. While our experience working with plaintiff law firms helps us recognize a great case when we see one, we will custom-tailor our Nexium and Prilosec case intake specifications to match the exact criteria you are seeking. So, if your firm has specific Nexium and Prilosec qualifying case criteria you would like us to use, we can train our intake specialists to apply the criteria to each phone call and email they receive. By getting rid of the middle man, Leading Justice offers clients an opportunity for internal cash buys of Nexium and Prilosec data with no chance of fraud.
Prilosec and Nexium Side Effect Litigation
Proton pump inhibitors (PPI) like Nexium (esomeprazole) and Prilosec (omeprazole) are commonly prescribed to individuals suffering from symptoms of frequent heartburn, acid reflux or gastroesophageal reflux disease (GERD), and work by reducing the amount of acid produced in the stomach. However, because stomach acid plays an important role in the body’s ability to absorb nutrients, protect itself against infection and properly digest food, Nexium, Prilosec and other proton pump inhibitors may actually cause serious adverse health consequences for users, including increasing their risk of kidney damage and kidney disease. Research has also shown that the longer a PPI is taken, the higher the risk of chronic kidney disease.
Nexium, Prilosec and other PPI medications have been the subject of serious concern since back in 2006, when the drugs were first linked to side effects like bone fractures and heart attacks. A recent study published in JAMA Internal Medicine in January 2016 showed that the use of popular proton pump inhibitors like Nexium and Prilosec may be associated with long-term kidney damage, and former users of the heartburn medications are now pursing legal claims against the drug manufacturing companies, alleging that the risk was never brought to the attention of consumers or medical professionals. As more sufferers of heartburn and acid reflux become aware of the potential for Nexium and Prilosec to cause kidney damage in users, additional claims are expected to be brought in the future.